Your browser doesn't support javascript.
loading
Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.
Gudernova, Iva; Balek, Lukas; Varecha, Miroslav; Kucerova, Jana Fialova; Kunova Bosakova, Michaela; Fafilek, Bohumil; Palusova, Veronika; Uldrijan, Stjepan; Trantirek, Lukas; Krejci, Pavel.
Afiliação
  • Gudernova I; Department of Biology, Faculty of Medicine, 62500 Brno, Czech Republic.
  • Balek L; Department of Biology, Faculty of Medicine, 62500 Brno, Czech Republic.
  • Varecha M; Department of Biology, Faculty of Medicine, 62500 Brno, Czech Republic.
  • Kucerova JF; International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic.
  • Kunova Bosakova M; Department of Biology, Faculty of Medicine, 62500 Brno, Czech Republic.
  • Fafilek B; Department of Biology, Faculty of Medicine, 62500 Brno, Czech Republic.
  • Palusova V; Department of Biology, Faculty of Medicine, 62500 Brno, Czech Republic.
  • Uldrijan S; International Clinical Research Center, St. Anne's University Hospital, 65691 Brno, Czech Republic.
  • Trantirek L; Department of Biology, Faculty of Medicine, 62500 Brno, Czech Republic.
  • Krejci P; Department of Biology, Faculty of Medicine, 62500 Brno, Czech Republic.
Oncotarget ; 8(65): 109319-109331, 2017 12 12.
Article em En | MEDLINE | ID: mdl-29312610

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: República Tcheca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: República Tcheca